Auto Amazon Links: No products found. Blocked by captcha.
The United Kingdom has launched a significant new screening trial focused on prostate cancer, marking the largest study of its kind in many years. Invitations to participate are being sent out to men by their general practitioners as part of this extensive research initiative. Supported by a £42 million investment from Prostate Cancer UK alongside the National Institute for Health and Care Research, the trial aims to identify more effective ways of detecting prostate cancer early.
Leading the study is Hashim Ahmed, who emphasizes the trial’s potential impact, describing the recruitment phase as a critical milestone. “Transform is truly game-changing… the start of recruitment today marks a pivotal step towards getting the results men urgently need to make prostate cancer diagnosis safe and more effective so that we can unlock the potential of prostate cancer screening in the UK,” he stated. The trial targets men aged 50 to 74, with the inclusion of younger participants from age 45 specifically for black men, given their higher risk levels compared to white men.
The research will explore the use of rapid MRI imaging combined with prostate-specific antigen (PSA) tests to enhance diagnostic accuracy. Currently, PSA testing, which measures PSA protein levels in the blood, presents limitations by identifying cancers that may not require treatment while missing others that do. Additionally, the trial will assess the effectiveness of genetic testing based on DNA obtained from saliva, comparing it with PSA results to determine a more accurate diagnostic method.
Matthew Hobbs, director of research at Prostate Cancer UK, highlighted the challenges with existing diagnostic approaches, pointing out the difficulties in detecting aggressive cancers early. He remarked, “We hear from men who were diagnosed late, whose lives may have been saved if they’d been screened or tested earlier. We also hear from a lot of men who have suffered incontinence or impotence because of treatments they had. Some of those men didn’t need to have those treatments, and that’s the harm that we need to try to avoid.” The trial arrives just ahead of a decision by the National Screening Committee on whether to endorse a formal prostate cancer screening programme across the NHS, a move that could prove transformative in reducing premature deaths related to the disease
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.